Cell and tissue technologies are becoming the third most important form of therapy alongside medication and surgery. In the future, these technologies may provide new solutions to diseases and traumas which currently don’t have effective treatments.

Our goal at the Human Spare Parts research program is to research and develop innovative stem cell based technologies and solutions for the needs of new therapies and drugs.

With over 25 treated patients and the largest bone deficiency treatments in the world, we are the forerunners in stem cell research. Our findings have been encouraging, but there is still a lot more research to be done.

If you are interested in contributing in our research program or collaborating, please contact us.

On behalf of our cross-disciplinary research team,

Program Manager Juho Väisänen

juho.vaisanen@biomeditech.fi

+358 40 1909834